New Urology Products & Services
Newly available urology products and services from Olympus, the National Institutes of Health, Spectrum Surgical Instruments Corp., and Midmark.
New LESS tools include instrument access port, videoscope
Center Valley, PA-Olympus recently introduced three surgical instruments designed specifically for laparo-endoscopic single-site surgery (LESS). The devices include the QuadPort, a disposable multi-instrument access port that can simultaneously accommodate up to four instruments through a single incision; the HiQ LS curved 5-mm hand instruments, which contain a shaft with curved distal and proximal ends to prevent interference with other LESS surgical devices inside the body; and the EndoEYE LS Laparo-Thoraco Videoscope, which incorporates a deflectable control section to help prevent interference with other devices externally.
For more information, visit http://www.olympusamerica.com/.
Bethesda, MD- http://ResearchMatch.org/ ( http://www.researchmatch.org/), a new, not-for-profit secure Web site, is a national research study recruitment registry. The site, created by medical research institutions affiliated with the National Institutes of Health, offers a free, safe, and easy-to-use way for volunteers to connect with thousands of researchers conducting research on diseases.
For more information, visit http://www.nih.gov/.
Internet-based tool provides detailed instrument repair tracking
For more information, visit http://www.spectrumsurgical.com/.
Mobile workstation helps integrate EMRs, other IT devices
For more information, visit http://www.midmark.com/.
Book discusses 'exploitation' of prostate cancer patients
Pittsburgh-The PSA test has led to the exploitation of prostate cancer patients, who are often treated unnecessarily following diagnosis, Anthony H. Horan, MD argues in his book, The Big Scare: The Business of Prostate Cancer. In the book, published by SterlingHouse Publisher Inc., Dr. Horan uses medical facts, statistics, and his own experience as a urologist to present his case on why the majority of prostate cancer patients should be treated with minimal cryosurgery or not be treated at all.
For more information, visit http://www.sterlinghousepublisher.com/.
Study finds disparities in management of mCSPC
April 17th 2024“These findings suggest that guideline recommended treatment intensification remains low for patients with mCSPC in both Medicare and the Veterans Health Administration, but especially for Black patients,” says Daniel J. George, MD.
